EXPRESSION OF COMPLEMENT COMPONENTS OF THE ALTERNATIVE PATHWAY BY GLIOMA CELL-LINES

被引:0
|
作者
GASQUE, P [1 ]
JULEN, N [1 ]
ISCHENKO, AM [1 ]
PICOT, C [1 ]
MAUGER, C [1 ]
CHAUZY, C [1 ]
RIPOCHE, J [1 ]
FONTAINE, M [1 ]
机构
[1] CTR HENRI BECQUEREL,IMMUNOCHEM LAB,F-76038 ROUEN,FRANCE
来源
JOURNAL OF IMMUNOLOGY | 1992年 / 149卷 / 04期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Glioma cell lines express proteins of the complement alternative pathway, namely C3, factor B, factor H, and factor 1. Secretion of these proteins was shown by a sensitive and specific ELISA. C3 and factor H were rapidly secreted by glioma cell line CB193 and reached a concentration of 140 ng/ml/10(6) cells after 72 h of culture. Factor B and factor I were secreted at a lower rate and reached concentrations of 25 and 15 ng/ml/10(6) cells, respectively. Western blot and immunoprecipitation experiments showed that secreted proteins were identical to the corresponding plasma proteins. For factor H, besides the well known 150-kDa species, an additional polypeptide of 45 kDa with factor H immunoreactivity was observed. This species corresponded to the N-terminal truncated form found in plasma. In preliminary experiments, we observed control of these syntheses by cytokines. IL-1-beta significantly increased C3 secretion, with no effect on factor H. Secretion of factor H was enhanced by IFN-gamma. These results show that a glioma cell line could be a useful tool to study complement biosynthesis by glial cells in humans.
引用
收藏
页码:1381 / 1387
页数:7
相关论文
共 50 条
  • [21] COMPLEMENT GENE-EXPRESSION IN NEUROBLASTOMA AND ASTROCYTOMA CELL-LINES OF HUMAN-ORIGIN
    WALKER, DG
    MCGEER, PL
    NEUROSCIENCE LETTERS, 1993, 157 (01) : 99 - 102
  • [22] INDUCTION OF EXPRESSION OF GLIA-ASSOCIATED AND GLIOMA-ASSOCIATED ANTIGENS (GAA) IN HUMAN GLIOMA CELL-LINES
    BILZER, T
    STAVROU, D
    WECHSLER, W
    BRITISH JOURNAL OF CANCER, 1989, 59 (02) : 316 - 316
  • [23] DISTRIBUTION OF TENASCIN IN HUMAN GLIOMA AND MESENCHYMAL CELL-LINES
    MURMAN, DL
    MCCOMB, RD
    CLINICAL RESEARCH, 1988, 36 (06): : A923 - A923
  • [24] Molecular characterisation of paediatric and adult glioma cell-lines
    Bax, Dorine A.
    Marshall, Lynley
    Gaspar, Nathalie
    Little, Suzie
    Swansbury, John
    Hargrave, Darren
    Ellison, David
    Pearson, Andrew
    Jones, Chris
    CELLULAR ONCOLOGY, 2007, 29 (02) : 133 - 134
  • [25] KARYOTYPE ANALYSES OF 20 HUMAN GLIOMA CELL-LINES
    WESTPHAL, M
    HANSEL, M
    HAMEL, W
    KUNZMANN, R
    HOLZEL, F
    ACTA NEUROCHIRURGICA, 1994, 126 (01) : 17 - 26
  • [26] Altered expression of ZEB1 correlates with invasiveness in glioma cell-lines, not with clinical prognosis
    Lee, Jae-Hyuk
    Lee, Kyung-Hwa
    Kim, Dong-Yi
    CANCER SCIENCE, 2018, 109 : 1354 - 1354
  • [27] EXPRESSION OF GLIAL FIBRILLARY ACIDIC PROTEIN IN HUMAN GLIOMA CELL-LINES AS DETECTED BY MOLECULAR HYBRIDIZATION
    DEWHURST, S
    STEVENSON, M
    MCCOMB, RD
    VOLSKY, DJ
    ACTA NEUROPATHOLOGICA, 1987, 73 (04) : 383 - 386
  • [28] LACK OF EXPRESSION OF TUMOR-SUPPRESSOR GENES IN HUMAN-MALIGNANT GLIOMA CELL-LINES
    GODBOUT, R
    MIYAKOSHI, J
    DOBLER, KD
    ANDISON, R
    MATSUO, K
    ALLALUNISTURNER, MJ
    TAKEBE, H
    DAY, RS
    ONCOGENE, 1992, 7 (09) : 1879 - 1884
  • [29] STUDIES ON THE DRUG SENSITIVITY OF HUMAN GLIOMA CELL-LINES IN CULTURE
    MERRY, S
    FRESHNEY, RI
    KAYE, SB
    BRITISH JOURNAL OF CANCER, 1983, 48 (01) : 118 - 118
  • [30] CHARACTERIZATION OF 4 HUMAN-MALIGNANT GLIOMA CELL-LINES
    STUDER, A
    DISERENS, AC
    GAIDE, AC
    MATTHIEU, JM
    CARREL, S
    STAVROU, D
    DETRIBOLET, N
    ACTA NEUROPATHOLOGICA, 1985, 66 (03) : 208 - 217